Body Mass Index Is Associated with Decreased Response to Initial and Delayed Treatment with Dose Escalated Infliximab in Patients with Recent Onset Rheumatoid Arthritis

Author(s):
Heimans, L.; Broek, M. van den; Dirven, L.; Schouffoer, A.A.; Speyer, I.; Kerstens, P.J.S.M.; Huizinga, T.W.J. (0000-0001-7033-7520); Lems, W.F.; Allaart, C.F.
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-10-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 10, p. S156-S157
hdl
1887/117957